BSX logo

Boston Scientific Corporation (BSX) EBITDA

Annual EBITDA:

$3.44B-$3.00M(-0.09%)
December 31, 2024

Summary

  • As of today, BSX annual EBITDA is $3.44 billion, with the most recent change of -$3.00 million (-0.09%) on December 31, 2024.
  • During the last 3 years, BSX annual EBITDA has risen by +$933.00 million (+37.17%).
  • BSX annual EBITDA is now -0.09% below its all-time high of $3.45 billion, reached on December 31, 2023.

Performance

BSX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

Quarterly EBITDA:

$1.38B+$125.00M(+9.94%)
September 30, 2025

Summary

  • As of today, BSX quarterly EBITDA is $1.38 billion, with the most recent change of +$125.00 million (+9.94%) on September 30, 2025.
  • Over the past year, BSX quarterly EBITDA has increased by +$402.00 million (+40.98%).
  • BSX quarterly EBITDA is now at all-time high.

Performance

BSX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

TTM EBITDA:

$4.80B+$402.00M(+9.14%)
September 30, 2025

Summary

  • As of today, BSX TTM EBITDA is $4.80 billion, with the most recent change of +$402.00 million (+9.14%) on September 30, 2025.
  • Over the past year, BSX TTM EBITDA has increased by +$941.00 million (+24.39%).
  • BSX TTM EBITDA is now at all-time high.

Performance

BSX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBSXincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

BSX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-0.1%+41.0%+24.4%
3Y3 Years+37.2%+85.9%+60.9%
5Y5 Years+58.6%+154.7%+145.1%

BSX EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-0.1%+37.2%at high+86.1%at high+61.1%
5Y5-Year-0.1%+145.1%at high+198.7%at high+179.0%
All-TimeAll-Time-0.1%+208.8%at high+1545.1%at high>+9999.0%

BSX EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$1.38B(+9.9%)
$4.80B(+9.1%)
Jun 2025
-
$1.26B(+3.0%)
$4.40B(+4.8%)
Mar 2025
-
$1.22B(+30.3%)
$4.20B(+7.0%)
Dec 2024
$3.44B(-0.1%)
$937.00M(-4.5%)
$3.92B(+1.7%)
Sep 2024
-
$981.00M(-7.3%)
$3.86B(+3.3%)
Jun 2024
-
$1.06B(+11.6%)
$3.74B(+5.9%)
Mar 2024
-
$948.00M(+8.8%)
$3.53B(+4.4%)
Dec 2023
$3.45B(+25.4%)
$871.00M(+1.4%)
$3.38B(+3.9%)
Sep 2023
-
$859.00M(+1.2%)
$3.25B(+3.7%)
Jun 2023
-
$849.00M(+6.1%)
$3.14B(+2.9%)
Mar 2023
-
$800.00M(+7.7%)
$3.05B(+2.3%)
Dec 2022
$2.75B(+9.4%)
$743.00M(-0.1%)
$2.98B(-0.1%)
Sep 2022
-
$744.00M(-2.2%)
$2.98B(+1.0%)
Jun 2022
-
$761.00M(+4.1%)
$2.95B(-0.4%)
Mar 2022
-
$731.00M(-2.1%)
$2.97B(+3.6%)
Dec 2021
$2.51B(+78.6%)
$747.00M(+4.6%)
$2.86B(+11.0%)
Sep 2021
-
$714.00M(-7.8%)
$2.58B(+7.1%)
Jun 2021
-
$774.00M(+23.2%)
$2.41B(+30.3%)
Mar 2021
-
$628.00M(+35.6%)
$1.85B(+7.4%)
Dec 2020
$1.41B(-35.3%)
$463.00M(-14.7%)
$1.72B(-12.2%)
Sep 2020
-
$543.00M(+153.7%)
$1.96B(-5.4%)
Jun 2020
-
$214.00M(-57.2%)
$2.07B(-17.9%)
Mar 2020
-
$500.00M(-28.7%)
$2.52B(-5.9%)
Dec 2019
$2.17B(-15.1%)
$701.00M(+7.2%)
$2.68B(+1.2%)
Sep 2019
-
$654.00M(-1.7%)
$2.65B(+0.8%)
Jun 2019
-
$665.00M(+1.1%)
$2.63B(+0.0%)
Mar 2019
-
$658.00M(-1.6%)
$2.62B(-0.3%)
Dec 2018
$2.56B(+27.5%)
$669.00M(+5.7%)
$2.63B(+0.1%)
Sep 2018
-
$633.00M(-4.7%)
$2.63B(+1.8%)
Jun 2018
-
$664.00M(-0.3%)
$2.58B(+2.5%)
Mar 2018
-
$666.00M(0.0%)
$2.52B(+6.4%)
Dec 2017
$2.01B(+63.8%)
$666.00M(+13.7%)
$2.37B(+6.0%)
Sep 2017
-
$586.00M(-2.7%)
$2.23B(+2.1%)
Jun 2017
-
$602.00M(+17.1%)
$2.19B(+4.5%)
Mar 2017
-
$514.00M(-3.4%)
$2.09B(+2.0%)
Dec 2016
$1.23B(+204.0%)
$532.00M(-1.3%)
$2.05B(+27.6%)
Sep 2016
-
$539.00M(+6.1%)
$1.61B(+8.7%)
Jun 2016
-
$508.00M(+7.6%)
$1.48B(+8.8%)
Mar 2016
-
$472.00M(+436.4%)
$1.36B(+5.3%)
Dec 2015
$403.00M(-6.7%)
$88.00M(-78.5%)
$1.29B(-16.5%)
Sep 2015
-
$410.00M(+5.4%)
$1.54B(+1.8%)
Jun 2015
-
$389.00M(-3.5%)
$1.52B(-0.3%)
Mar 2015
-
$403.00M(+17.8%)
$1.52B(+0.7%)
Dec 2014
$432.00M(-45.3%)
$342.00M(-10.7%)
$1.51B(-2.6%)
Sep 2014
-
$383.00M(-2.5%)
$1.55B(-0.2%)
Jun 2014
-
$393.00M(+0.3%)
$1.55B(-1.3%)
Mar 2014
-
$392.00M(+2.6%)
$1.57B(+0.8%)
Dec 2013
$790.00M(+125.0%)
$382.00M(-1.0%)
$1.56B(-3.3%)
Sep 2013
-
$386.00M(-6.5%)
$1.61B(-1.8%)
Jun 2013
-
$413.00M(+9.0%)
$1.64B(-0.7%)
Mar 2013
-
$379.00M(-12.9%)
$1.65B(-1.4%)
Dec 2012
-$3.16B(-292.9%)
$435.00M(+4.6%)
$1.68B(+1.2%)
Sep 2012
-
$416.00M(-1.9%)
$1.66B(+0.4%)
Jun 2012
-
$424.00M(+5.5%)
$1.65B(-3.3%)
Mar 2012
-
$402.00M(-3.1%)
$1.71B(-7.2%)
Dec 2011
$1.64B(+1023.3%)
$415.00M(+1.2%)
$1.84B(-4.3%)
Sep 2011
-
$410.00M(-14.6%)
$1.92B(-3.0%)
Jun 2011
-
$480.00M(-10.3%)
$1.98B(+1.7%)
Mar 2011
-
$535.00M(+7.4%)
$1.95B(+3.2%)
Dec 2010
$146.00M(+317.9%)
$498.00M(+6.0%)
$1.89B(-2.2%)
Sep 2010
-
$470.00M(+5.1%)
$1.93B(-2.9%)
Jun 2010
-
$447.00M(-5.9%)
$1.99B(-4.7%)
Mar 2010
-
$475.00M(-12.0%)
$2.09B(+1.4%)
Dec 2009
-$67.00M(+90.4%)
$540.00M(+2.5%)
$2.06B(+2.5%)
Sep 2009
-
$527.00M(-3.3%)
$2.01B(+1.2%)
Jun 2009
-
$545.00M(+21.9%)
$1.99B(-0.5%)
Mar 2009
-
$447.00M(-8.8%)
$2.00B(-7.6%)
Dec 2008
-$699.00M
$490.00M(-2.6%)
$2.16B(-4.3%)
Sep 2008
-
$503.00M(-9.4%)
$2.26B(-0.3%)
DateAnnualQuarterlyTTM
Jun 2008
-
$555.00M(-9.0%)
$2.26B(-0.8%)
Mar 2008
-
$610.00M(+3.7%)
$2.28B(+4.5%)
Dec 2007
$919.00M(-52.9%)
$588.00M(+15.5%)
$2.18B(+1.3%)
Sep 2007
-
$509.00M(-11.3%)
$2.15B(+4.4%)
Jun 2007
-
$574.00M(+12.3%)
$2.06B(+5.6%)
Mar 2007
-
$511.00M(-8.8%)
$1.95B(-3.1%)
Dec 2006
$1.95B(+25.2%)
$560.00M(+34.0%)
$2.02B(+0.9%)
Sep 2006
-
$418.00M(-9.9%)
$2.00B(-5.6%)
Jun 2006
-
$464.00M(-19.2%)
$2.12B(-6.2%)
Mar 2006
-
$574.00M(+5.7%)
$2.26B(-3.4%)
Dec 2005
$1.56B(-18.6%)
$543.00M(+1.1%)
$2.34B(+0.3%)
Sep 2005
-
$537.00M(-11.2%)
$2.33B(+3.1%)
Jun 2005
-
$605.00M(-7.4%)
$2.26B(+3.1%)
Mar 2005
-
$653.00M(+22.1%)
$2.19B(+20.1%)
Dec 2004
$1.91B(+105.8%)
$535.00M(+14.6%)
$1.83B(+20.3%)
Sep 2004
-
$467.00M(-13.2%)
$1.52B(+20.4%)
Jun 2004
-
$538.00M(+88.1%)
$1.26B(+35.7%)
Mar 2004
-
$286.00M(+26.0%)
$929.00M(+10.9%)
Dec 2003
$930.00M(+8.6%)
$227.00M(+8.1%)
$838.00M(-4.3%)
Sep 2003
-
$210.00M(+1.9%)
$876.00M(+5.3%)
Jun 2003
-
$206.00M(+5.6%)
$832.00M(+8.1%)
Mar 2003
-
$195.00M(-26.4%)
$770.00M(+7.5%)
Dec 2002
$856.00M(+39.4%)
$265.00M(+59.6%)
$716.00M(-10.3%)
Sep 2002
-
$166.00M(+15.3%)
$798.00M(+3.1%)
Jun 2002
-
$144.00M(+2.1%)
$774.00M(+6.9%)
Mar 2002
-
$141.00M(-59.4%)
$724.00M(-0.1%)
Dec 2001
$614.00M(-28.3%)
$347.00M(+144.4%)
$725.00M(+23.5%)
Sep 2001
-
$142.00M(+51.1%)
$587.00M(-6.2%)
Jun 2001
-
$94.00M(-33.8%)
$626.00M(-15.1%)
Mar 2001
-
$142.00M(-32.1%)
$737.00M(-6.4%)
Dec 2000
$856.00M(-5.2%)
$209.00M(+15.5%)
$787.00M(-7.4%)
Sep 2000
-
$181.00M(-11.7%)
$850.00M(+4.0%)
Jun 2000
-
$205.00M(+6.8%)
$817.00M(-2.4%)
Mar 2000
-
$192.00M(-29.4%)
$837.00M(-2.3%)
Dec 1999
$903.00M(+45.6%)
$272.00M(+83.8%)
$857.00M(+6.9%)
Sep 1999
-
$148.00M(-34.2%)
$801.89M(+2.2%)
Jun 1999
-
$225.00M(+6.1%)
$784.86M(+16.1%)
Mar 1999
-
$212.00M(-2.3%)
$675.86M(+17.6%)
Dec 1998
$620.00M(+21.8%)
$216.89M(+65.6%)
$574.86M(+42.4%)
Sep 1998
-
$130.97M(+12.9%)
$403.77M(+1.6%)
Jun 1998
-
$116.00M(+4.5%)
$397.30M(-5.4%)
Mar 1998
-
$111.00M(+142.4%)
$420.10M(-0.4%)
Dec 1997
$509.00M(+23.6%)
$45.80M(-63.2%)
$421.90M(+8.3%)
Sep 1997
-
$124.50M(-10.3%)
$389.50M(+4.1%)
Jun 1997
-
$138.80M(+23.0%)
$374.10M(+6.6%)
Mar 1997
-
$112.80M(+741.8%)
$350.90M(+16.0%)
Dec 1996
$411.80M(+37.3%)
$13.40M(-87.7%)
$302.50M(-4.8%)
Sep 1996
-
$109.10M(-5.6%)
$317.60M(+10.6%)
Jun 1996
-
$115.60M(+79.5%)
$287.20M(+16.4%)
Mar 1996
-
$64.40M(+126.0%)
$246.80M(-3.8%)
Dec 1995
$299.90M(+115.8%)
$28.50M(-63.8%)
$256.60M(-3.5%)
Sep 1995
-
$78.70M(+4.7%)
$265.90M(+21.4%)
Jun 1995
-
$75.20M(+1.3%)
$219.00M(+25.5%)
Mar 1995
-
$74.20M(+96.3%)
$174.50M(+34.2%)
Dec 1994
$139.00M(+20.9%)
$37.80M(+18.9%)
$130.00M(+3.1%)
Sep 1994
-
$31.80M(+3.6%)
$126.10M(+2.8%)
Jun 1994
-
$30.70M(+3.4%)
$122.70M(+2.6%)
Mar 1994
-
$29.70M(-12.4%)
$119.60M(+4.1%)
Dec 1993
$115.00M(+18.1%)
$33.90M(+19.4%)
$114.90M(+6.7%)
Sep 1993
-
$28.40M(+2.9%)
$107.70M(+2.7%)
Jun 1993
-
$27.60M(+10.4%)
$104.90M(+4.4%)
Mar 1993
-
$25.00M(-6.4%)
$100.50M(+3.1%)
Dec 1992
$97.40M(+31.8%)
$26.70M(+4.3%)
$97.50M(+491.6%)
Sep 1992
-
$25.60M(+10.3%)
-$24.90M(-364.9%)
Jun 1992
-
$23.20M(+5.5%)
$9.40M(-77.7%)
Mar 1992
-
$22.00M(+123.0%)
$42.10M(-40.4%)
Dec 1991
$73.90M
-$95.70M(-259.8%)
$70.60M(-57.5%)
Sep 1991
-
$59.90M(+7.2%)
$166.30M(+56.3%)
Jun 1991
-
$55.90M(+10.7%)
$106.40M(+110.7%)
Mar 1991
-
$50.50M
$50.50M

FAQ

  • What is Boston Scientific Corporation annual EBITDA?
  • What is the all-time high annual EBITDA for Boston Scientific Corporation?
  • What is Boston Scientific Corporation annual EBITDA year-on-year change?
  • What is Boston Scientific Corporation quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for Boston Scientific Corporation?
  • What is Boston Scientific Corporation quarterly EBITDA year-on-year change?
  • What is Boston Scientific Corporation TTM EBITDA?
  • What is the all-time high TTM EBITDA for Boston Scientific Corporation?
  • What is Boston Scientific Corporation TTM EBITDA year-on-year change?

What is Boston Scientific Corporation annual EBITDA?

The current annual EBITDA of BSX is $3.44B

What is the all-time high annual EBITDA for Boston Scientific Corporation?

Boston Scientific Corporation all-time high annual EBITDA is $3.45B

What is Boston Scientific Corporation annual EBITDA year-on-year change?

Over the past year, BSX annual EBITDA has changed by -$3.00M (-0.09%)

What is Boston Scientific Corporation quarterly EBITDA?

The current quarterly EBITDA of BSX is $1.38B

What is the all-time high quarterly EBITDA for Boston Scientific Corporation?

Boston Scientific Corporation all-time high quarterly EBITDA is $1.38B

What is Boston Scientific Corporation quarterly EBITDA year-on-year change?

Over the past year, BSX quarterly EBITDA has changed by +$402.00M (+40.98%)

What is Boston Scientific Corporation TTM EBITDA?

The current TTM EBITDA of BSX is $4.80B

What is the all-time high TTM EBITDA for Boston Scientific Corporation?

Boston Scientific Corporation all-time high TTM EBITDA is $4.80B

What is Boston Scientific Corporation TTM EBITDA year-on-year change?

Over the past year, BSX TTM EBITDA has changed by +$941.00M (+24.39%)
On this page